Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × belinostat × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 3 Ovarian Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Thymoma 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liver Diseases 1 Leukemia-Lymphoma, Adult T-Cell 1 Congenital Abnormalities 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Brenner Tumor 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡